Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michelle L. Gumz, Lisa R. Stow, I. Jeanette Lynch, Megan M. Greenlee, Alicia Rudin, Brian D. Cain, David R. Weaver, Charles S. Wingo
Published in Volume 119, Issue 8
J Clin Invest. 2009; 119(8):2423–2434 doi:10.1172/JCI36908
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
Per1 is upregulated by aldosterone in mIMCD-3 cells.

(A) QPCR was used to calculate changes in gene expression of Per1, Per2, Sgk1, and αENaC in aldosterone-treated compared with vehicle-treated cells. Fold change values were normalized against actin levels, relative to the vehicle control, and are presented as mean ± SD; n = 3. *P < 0.05 versus vehicle control. (B) Total cell lysate was collected from mIMCD-3 cells treated with vehicle or aldosterone for 6 hours. Western blot analysis was performed using an anti-Per1 antibody. GAPDH was used as a loading control.